BEATW Market Analysis

News & Sentiment

1 article · sorted by date

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio
EPS (TTM)$-0.500.0% YoY
Profit margin0.0%HEALTHCARE
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-164.2%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
Last earnings
Jun 30, 2021 · Estimate $0.00 · Reported $-0.26
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Heartbeam Inc. Warrant

Company profile

Heartbeam Inc. Warrant (BEATW) represents a strategic investment aligned with Heartbeam Inc., a pioneering healthcare technology firm focused on transforming cardiac diagnostics through the integration of artificial intelligence and digital solutions. The company's cutting-edge platform enhances diagnostic precision for myocardial infarctions, facilitating timely interventions that significantly improve patient care outcomes. As the demand for innovative remote monitoring and telehealth services continues to escalate, Heartbeam is well-positioned to capture substantial market growth, making…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
NONE
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$0.56
52W low$0.02

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer